Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel-Reference-Cited by-同舟云学术

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel

Published:2017-08-01 Issue:10 Volume:24 Page:2818-2826
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

McLaughlin Sarah A.,Staley Alicia C.,Vicini Frank,Thiruchelvam Paul,Hutchison Nancy A.,Mendez Jane,MacNeill Fiona,Rockson Stanley G.,DeSnyder Sarah M.,Klimberg Suzanne,Alatriste Michael,Boccardo Francesco,Smith Mark L.,Feldman Sheldon M.

Funder

ImpediMed

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-017-5982-4/fulltext.html

Reference112 articles.

1. Rockson SG. Update on the biology and treatment of lymphedema. Curr Treat Options Cardiovasc Med. 2012;14:184–92.

2. Shih YC, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27:2007–14.

3. Basta MN, et al. Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg. 2016;211:133–41.